Clinical Efficacy and Vaccine Potency Testing from a Single Platform
Analytics for coronavirus vaccines compatible with next generation vaccine platform technology
Accelerate coronavirus vaccine development by utilizing VaxArray’s rapid analytical platform to empower vaccine clinical efficacy studies, investigate population-level seroprevalence, or provide insight into vaccine manufacturing steps. VaxArray is a powerful platform technology, rapidly deployed to address the need of manufacturers developing life saving coronavirus vaccines. Use the VaxArray Coronavirus Spike Protein Assay for analysis of vaccine samples, or use the VaxArray Coronavirus SeroAssay for simultaneous measurements of antibody response to SARS-CoV-2 antigens and other endemic human coronaviruses.
Request more information